By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Synthetic Biologics, Inc. (SYN) And Fujifilm Diosynth Biotechnologies Announce Significant Improvement In API Manufacturing Of SYN-004 For The Prevention Of C. Difficile 8/28/2014 11:32:39 AM
Synthetic Biologics, Inc. (SYN) Announces Presentation Of Poster for SYN-004 C. difficile Program At IDWeek 2014™ 8/26/2014 9:38:48 AM
Synthetic Biologics, Inc. (SYN) Announces Late-Breaking Poster Presentation For C. Difficile Program At 54th ICAAC 8/19/2014 8:20:54 AM
Synthetic Biologics, Inc. (SYN) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/14/2014 8:54:49 AM
Synthetic Biologics, Inc. (SYN) To Host Irritable Bowel Syndrome (IBS) Investor Day 8/13/2014 10:21:35 AM
Synthetic Biologics, Inc. (SYN)' Academic Collaborator To Present Novel Monoclonal Antibody Combination For Treatment Of Whooping Cough (Pertussis) At 54th ICAAC 8/12/2014 9:08:21 AM
Synthetic Biologics, Inc. (SYN) To Report Second Quarter 2014 Financial Results 8/7/2014 9:24:43 AM
Synthetic Biologics, Inc. (SYN) On Track To Initiate Clinical Program For SYN-004 To Protect Against C. difficile 8/5/2014 6:14:48 AM
Expanded Data On Disability And Cognitive Improvements In Phase 2 Study Of Synthetic Biologics, Inc. (SYN)' Trimesta™ In Multiple Sclerosis To Be Presented At 2014 Joint ACTRIMS-ECTRIMS Meeting 7/31/2014 8:01:05 AM
Synthetic Biologics, Inc. (SYN)' Academic Collaborator To Present Novel Monoclonal Antibody Combination For Treating Whooping Cough (Pertussis) At Gordon Research Conference 7/21/2014 12:00:48 PM
12345678910...
//-->